Expression and responsiveness of P2Y(2) receptors in human endometrial cancer cell lines

Citation
Ac. Katzur et al., Expression and responsiveness of P2Y(2) receptors in human endometrial cancer cell lines, J CLIN END, 84(11), 1999, pp. 4085-4091
Citations number
46
Categorie Soggetti
Endocrynology, Metabolism & Nutrition","Endocrinology, Nutrition & Metabolism
Journal title
JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
ISSN journal
0021972X → ACNP
Volume
84
Issue
11
Year of publication
1999
Pages
4085 - 4091
Database
ISI
SICI code
0021-972X(199911)84:11<4085:EAROPR>2.0.ZU;2-2
Abstract
In single endometrial carcinoma HEC-1A and Ishikawa cells, ATP induced a ra pid and extracellular Ca2+-independent rise in cytosolic Ca2+ concentration ([Ca2+](i)) in a dose-dependent manner, with an ED50 of about 10 mu M. The spike phase was followed by a sustained plateau phase that was dependent o n Ca2+ influx through voltage-insensitive Ca2+ channels, whose gating was c ontrolled by a capacitative Ca2+ entry mechanism. ADP was less potent in ra ising the cystolic Ca2+ concentration, and AMP and adenosine were ineffecti ve. The order of agonist potency for this receptor was ATP = UTP > ATP-gamm a-S much greater than ADP. Several other agonists, including beta,gamma-met hylene-ATP, 2-MeS-ATP, and BzATP were ineffective. This ligand-selective pr ofile indicates the expression of the P2Y(2)R subtype in endometrial cells. Accordingly, reverse transcription-PCR using P2Y(2) primers amplified the expected transcript from both cell lines. The coupling of these receptors t o phospholipase C was confirmed by the ability of ATP to increase inositol 1,4,5-trisphosphate and diacylglycerol productions. These receptors are als o coupled to the phospholipase D-l pathway, leading to accumulation of phos phatidic;acid, Activation of P2Y(2) receptors by a slowly degradable ATP an alog, ATP-gamma-S, was associated with a significant suppression of cell pr oliferation without affecting the cellular apoptosis. These results indicat e that P2Y(2) receptors may participate in control of the cell cycle of end ometrial carcinoma cells.